Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1211210

Presence of high-risk HPVs, EBV, and MMTV in human triple-negative breast cancer


Gupta, Ishita; Ulamec, Monika; Perić-Balja, Melita; Ramić, Snježana; Al Moustafa, Ala-Eddin; Vranić, Semir; Al-Farsi, Halema F.
Presence of high-risk HPVs, EBV, and MMTV in human triple-negative breast cancer // Human Vaccines & Immunotherapeutics, 17 (2021), 11; 4457-4463 doi:10.1080/21645515.2021.1975452 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 1211210 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Presence of high-risk HPVs, EBV, and MMTV in human triple-negative breast cancer

Autori
Gupta, Ishita ; Ulamec, Monika ; Perić-Balja, Melita ; Ramić, Snježana ; Al Moustafa, Ala-Eddin ; Vranić, Semir ; Al-Farsi, Halema F.

Izvornik
Human Vaccines & Immunotherapeutics (2164-5515) 17 (2021), 11; 4457-4463

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
HPV ; EBV ; MMTV ; triple-negative breast cancer

Sažetak
Breast cancer, the most frequent disease amongst women worldwide, accounts for the highest cancer- related mortality rate. Triple-negative breast cancer (TNBC) subtype encompasses ~15% of all breast cancers and lack estrogen, progesterone, and HER2 receptors. Although risk factors for breast cancer are well-known, factors underpinning breast cancer onset and progression remain unknown. Recent studies suggest the plausible role of oncoviruses including human papillomaviruses (HPVs), Epstein-Barr virus (EBV), and mouse mammary tumor virus (MMTV) in breast cancer pathogenesis. However, the role of these oncoviruses in TNBC is still unclear. In the current study, we explored the status of high-risk HPVs, EBV, and MMTV in a well-defined TNBC cohort from Croatia in comparison to 16 normal/non TNBC samples (controls) using polymerase chain reaction assay. We found high-risk HPVs and EBV present in 37/70 (53%) and 25/70 (36%) of the cases, respectively. The most common HPV types are 52, 45, 31, 58 and 68. We found 16% of the samples positive for co-presence of high-risk HPVs and EBV. Moreover, our data revealed that 5/70 (7%) samples are positive for MMTV. In addition, only 2/70 (3%) samples had co-presence of HPVs, EBV, and MMTV without any significant association with the clinicopathological variables. While, 6/16 (37.5%) controls were positive for HPV (p = .4), EBV was absent in all controls (0/16, 0%) (p = .01). In addition, we did not find the co-presence of the oncoviruses in the controls (p > .05). Nevertheless, further investigations are essential to understand the underlying mechanisms of multiple-oncogenic viruses’ interaction in breast carcinogenesis, especially TNBC.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Ustanove:
Medicinski fakultet, Zagreb,
KBC "Sestre Milosrdnice"

Profili:

Avatar Url Melita Perić Balja (autor)

Avatar Url Snježana Ramić (autor)

Avatar Url Monika Ulamec (autor)

Poveznice na cjeloviti tekst rada:

doi

Citiraj ovu publikaciju:

Gupta, Ishita; Ulamec, Monika; Perić-Balja, Melita; Ramić, Snježana; Al Moustafa, Ala-Eddin; Vranić, Semir; Al-Farsi, Halema F.
Presence of high-risk HPVs, EBV, and MMTV in human triple-negative breast cancer // Human Vaccines & Immunotherapeutics, 17 (2021), 11; 4457-4463 doi:10.1080/21645515.2021.1975452 (međunarodna recenzija, članak, znanstveni)
Gupta, I., Ulamec, M., Perić-Balja, M., Ramić, S., Al Moustafa, A., Vranić, S. & Al-Farsi, H. (2021) Presence of high-risk HPVs, EBV, and MMTV in human triple-negative breast cancer. Human Vaccines & Immunotherapeutics, 17 (11), 4457-4463 doi:10.1080/21645515.2021.1975452.
@article{article, author = {Gupta, Ishita and Ulamec, Monika and Peri\'{c}-Balja, Melita and Rami\'{c}, Snje\v{z}ana and Al Moustafa, Ala-Eddin and Vrani\'{c}, Semir and Al-Farsi, Halema F.}, year = {2021}, pages = {4457-4463}, DOI = {10.1080/21645515.2021.1975452}, keywords = {HPV, EBV, MMTV, triple-negative breast cancer}, journal = {Human Vaccines and Immunotherapeutics}, doi = {10.1080/21645515.2021.1975452}, volume = {17}, number = {11}, issn = {2164-5515}, title = {Presence of high-risk HPVs, EBV, and MMTV in human triple-negative breast cancer}, keyword = {HPV, EBV, MMTV, triple-negative breast cancer} }
@article{article, author = {Gupta, Ishita and Ulamec, Monika and Peri\'{c}-Balja, Melita and Rami\'{c}, Snje\v{z}ana and Al Moustafa, Ala-Eddin and Vrani\'{c}, Semir and Al-Farsi, Halema F.}, year = {2021}, pages = {4457-4463}, DOI = {10.1080/21645515.2021.1975452}, keywords = {HPV, EBV, MMTV, triple-negative breast cancer}, journal = {Human Vaccines and Immunotherapeutics}, doi = {10.1080/21645515.2021.1975452}, volume = {17}, number = {11}, issn = {2164-5515}, title = {Presence of high-risk HPVs, EBV, and MMTV in human triple-negative breast cancer}, keyword = {HPV, EBV, MMTV, triple-negative breast cancer} }

Časopis indeksira:


  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font